Strumento inattivo

Altre lingue Pascal Biosciences Inc. Toronto S.E.

Azioni

PAS

CA7024781089

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Nevis Brands Trims Its Fiscal Q2 Loss Quarter-Over-Quarter	10/07
Nevis Brands Trims Fiscal Q2 Loss Quarter-Over-Quarter	10/07
Nevis Brands Reports Financial Results for Q2 2024	10/07
Nevis Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024	09/07
Nevis Brands Inc. Announces the Launch of Major Shots in Oregon	27/06
Nevis Brands Expands Major Brand with Launch of Gummies in Washington State	29/05
Nevis Brands Reports Announces the launch of Major(™) Gummies for Washington State	29/05
Nevis Brands Inc. Reports Announces the launch of Major(?) Gummies for Washington State	29/05
Nevis Brands Inc Receives Necessary State Regulatory Approvals and Is Completing Production on 3 New Products to Add to Its Existing Portfolio of Products for Sale in Washington State	09/05
Nevis Brands Expands Major Distribution with Exclusive Licensing Agreement in Mississippi	30/04
NEVIS BRANDS INC. Announces Licensing Agreement and Expansion of Major™ brands to Mississippi.	30/04
Nevis Brands Inc. and Stash House Distro LLC Announce Licensing Agreement and Expansion of Major Brands to Mississippi	30/04
Nevis Brands announces major shots are now for sale in dozens if dispensaries in Missouri	24/04
Nevis Brands Reports Financial Results for Q1 2024	16/04
Nevis Brands Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024	16/04
Nevis Brands releases financial numbers seeing a 44% increase in quarterly revenue	27/03
Nevis Brands' Fiscal Q4 Profit Falls, Reports Revenue; Down Over 15%	22/03
Nevis Brands' Fiscal Q4 Profit Falls, Reports Revenue	22/03
Nevis Brands Reports Financial Results for Fiscal Year 2023, Increases quarterly revenues by 44%	22/03
Nevis Brands Inc. Reports Earnings Results for the Full Year Ended November 30, 2023	21/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Pascal Biosciences Inc. Toronto S.E.

Azioni

PAS

CA7024781089

Altre lingue

Filtri